|
|
Editorials |
| The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus |
87 |
| Pierre Youinou
|
|
Full Article (PDF)
|
|
| The Antiphospholipid Syndrome and ‘Multiple Sclerosis’ |
89 |
| GRV Hughes
|
|
Full Article (PDF)
|
|
Papers |
The relationship between defects in lymphocyte production of transforming growth factor- 1 in systemic lupus erythematosus and disease activity or severity |
90 |
| K Ohtsuka,
JD Gray,
MM Stimmler & DA Horwitz
|
|
Abstract
Full Article (PDF)
|
|
| Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta |
95 |
| K Ohtsuka,
JD Gray,
FP Quismorio Jr,
W Lee & DA Horwitz
|
|
Abstract
Full Article (PDF)
|
|
| Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus |
103 |
| F Tjernström,
G Hellmer,
O Nived,
L Truedsson & G Sturfelt
|
|
Abstract
Full Article (PDF)
|
|
| Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? |
109 |
| JW IJdo,
AM Conti-Kelly,
P Greco,
M Abedi,
M Amos,
JM Provenzale & TP Greco
|
|
Abstract
Full Article (PDF)
|
|
| 2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels |
116 |
| J George,
B Gilburd,
P Langevitz,
Y Levy,
R Nezlin,
D Harats & Y Shoenfeld
|
|
Abstract
Full Article (PDF)
|
|
| [Anti-2 Glycoprotein I--2 Glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases |
121 |
| A Biasiolo,
P Rampazzo,
T Brocco,
F Barbero,
A Rosato & V Pengo
|
|
Abstract
Full Article (PDF)
|
|
| Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes |
127 |
| J Chapman,
M Cohen-Armon,
Y Shoenfeld & AD Korczyn
|
|
Abstract
Full Article (PDF)
|
|
| Anticardiolipin and anti-2glycoprotein-I antibodies in patients with systemic lupus erythematosus: Comparison between Colombians and Spaniards |
134 |
| E Cucurull,
LR Espinoza,
E Mendez,
JF Molina,
J Molina,
J Ordi-Ros & AE Gharavi
|
|
Abstract
Full Article (PDF)
|
|
| Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE |
142 |
| R Wu,
E Svenungsson,
I Gunnarsson,
B Andersson,
I Lundberg,
L Schäfer Elinder & J Frostegård
|
|
Abstract
Full Article (PDF)
|
|
| Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study |
151 |
| A Fernández-Nebro,
R Palacios-Muñoz,
J Gordillo,
M Abarca-Costalago,
M De Haro-Liger,
J Rodríguez-Andreu & P González-Santos
|
|
Abstract
Full Article (PDF)
|
|
Case Reports |
| Systemic lupus erythematosus complicated by necrotizing fasciitis |
157 |
| EA Mendez,
LM Espinoza,
M Harris,
J Angulo,
CV Sanders & LR Espinoza
|
|
Abstract
Full Article (PDF)
|
|
| Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature |
160 |
| RM Morlà,
R Ramos-Casals,
M García-Carrasco,
R Cervera,
J Font,
M Bruguera,
J Rojas-Rodríguez & M Ingelmo
|
|
Abstract
Full Article (PDF)
|
|
| Primary subcutaneous nocardial infection in a SLE patient |
164 |
| A Balbir-Gurman,
D Schapira & AM Nahir
|
|
Abstract
Full Article (PDF)
|
|
